AgeChem Venture Fund logo

AgeChem Venture Fund

North America, Quebec, Canada, Montréal

Description

The AgeChem Fund L.P. currently has $65 million under management and is seeking to invest in companies developing therapeutics targeting

Investor Profile

AgeChem Venture Fund has made 11 investments, with 0 in the past 12 months and 18% as lead.

Stage Focus

  • Series B (45%)
  • Series C (18%)
  • Series A (18%)
  • Series D (9%)
  • Series Unknown (9%)

Country Focus

  • United States (91%)
  • Canada (9%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Health Care
  • Biopharma
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does AgeChem Venture Fund frequently co-invest with?

Sofinnova Investments
North America, California, United States, Menlo Park
Co-Investments: 3
Athenian Venture Partners
North America, Florida, United States, Fort Lauderdale
Co-Investments: 3
Orchard Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 2
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 5
Domain Associates
North America, California, United States, San Diego
Co-Investments: 3
Kearny Venture Partners
North America, California, United States, San Francisco
Co-Investments: 3
Triathlon Medical Venture Partners
North America, Ohio, United States, Cincinnati
Co-Investments: 3
CC
North America, California, United States, San Francisco
Co-Investments: 3
Venture Investors
North America, Wisconsin, United States, Madison
Co-Investments: 3
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 3

What are some of recent deals done by AgeChem Venture Fund?

Sorbent Therapeutics

Sunnyvale, California, United States

Sorbent Therapeutics develops fluid-retaining polymers for kidney disease therapeutics.

BiopharmaBiotechnologyPharmaceutical
Series DMay 15, 2014
Amount Raised: $6,500,000
Aerpio Pharmaceuticals

Cincinnati, Ohio, United States

Aerpio Pharmaceuticals is a biotechnology company that develops small molecules and monoclonal antibodies for vascular diseases treatment.

BiotechnologyHealth CareTherapeutics
Series ANov 6, 2013
Amount Raised: $36,000,000
Akebia Therapeutics

Cambridge, Massachusetts, United States

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

BiotechnologyHealth CareTherapeutics
Series CJun 4, 2013
Amount Raised: $41,000,000
Sorbent Therapeutics

Sunnyvale, California, United States

Sorbent Therapeutics develops fluid-retaining polymers for kidney disease therapeutics.

BiopharmaBiotechnologyPharmaceutical
Series BJun 30, 2011
Amount Raised: $36,000,000
Akebia Therapeutics

Cambridge, Massachusetts, United States

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

BiotechnologyHealth CareTherapeutics
Series BApr 26, 2011
Amount Raised: $22,000,000
Conatus Pharmaceuticals

San Diego, California, United States

Conatus Pharmaceuticals is focused on the development of human therapeutics to treat liver failures and cancer.

BiotechnologyHealth CareTherapeutics
Series BFeb 11, 2011
Amount Raised: $20,000,000
Sorbent Therapeutics

Sunnyvale, California, United States

Sorbent Therapeutics develops fluid-retaining polymers for kidney disease therapeutics.

BiopharmaBiotechnologyPharmaceutical
Series BSep 13, 2010
Amount Raised: $21,800,000
Altair Therapeutics

San Diego, California, United States

Altair Therapeutics was a biopharmaceutical company that focused on developing therapeutics to treat human respiratory diseases.

BiopharmaBiotechnologyTherapeutics
Series BFeb 2, 2010
Amount Raised: $17,000,000
Ocera Therapeutics

Palo Alto, California, United States

Ocera Therapeutics is a biopharmaceutical company developing novel therapeutics for patients with acute and chronic liver diseases.

BiopharmaBiotechnologyTherapeutics
Series CFeb 20, 2008
Amount Raised: $35,500,000
Sonexa Therapeutics

San Diego, California, United States

Sonexa Therapeutics is a pharmaceutical company that develops drug treatments for Alzheimer's disease and related disorders.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series AJan 31, 2008
Amount Raised: $30,000,000